Richard F Little

23PUBLICATIONS
146CO-AUTHORS
Haematological tumoursLiquid biopsiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 09, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.

Sharon M Castellino, Hongli Li, Alex F Herrera

|May 19, 2025
Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131).

Mohamed A Gouda, Filip Janku, Ying Yuan

|Mar 27, 2025
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.

Uma Borate, Kelly Pugh, Allyson Waller

|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Mitchell R Smith, Opeyemi A Jegede, Peter Martin

|Jan 12, 2024
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.

Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert

|Nov 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.

Lakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi

Pageof 4

Frequent Collaborators

5 joint publications

Mark R Litzow

4 joint publications

Mrinal M Patnaik

4 joint publications

Uwe Platzbecker

4 joint publications

Rami S Komrokji